Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)

EU orphan designation number: EU/3/04/252
Active ingredient: Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)
Indication: Treatment of chronic myeloid leukemia
Sponsor: Accelsiors CRO & Consultancy Services GmbH
Hammersbacher Fussweg 24, D-82467 Garmisch-Partenkirchen, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2004 Centralised Orphan - Designation EMEA/OD/060/04 (2004)5566 of 21/12/2004
12/03/2009 Centralised Orphan - Removal of orphan designation from Community Register